What Makes Centenarians So Resistant to Disease?

The study demonstrated that centenarians represent a distinct group with exceptional biological resilience to age-related diseases. Compared with individuals from the same birth cohorts who did not reach 100 years of age, centenarians consistently showed lower age-specific incidence rates for almost all major chronic diseases.

Importantly, the findings indicate that centenarians not only delay the onset of disease but also avoid many major age-related diseases altogether. Despite living substantially longer, they exhibited a lower lifetime risk for nearly every disease included in the analysis, with hip fracture being the only notable exception.

This pattern was consistently observed across several major conditions, including stroke, myocardial infarction and multiple types of cancer, and was similar in both women and men.

These findings challenge the long-held assumption that a longer lifespan inevitably results in more years lived with chronic disease. Instead, they suggest that exceptional longevity is associated with greater biological resilience, enabling many centenarians to postpone—and in some cases completely avoid—the development of major age-related diseases.

This study provides encouraging evidence that healthy longevity is not simply about surviving chronic diseases for longer. Instead, exceptional longevity appears to be associated with greater resistance to developing many age-related diseases in the first place.

Understanding the biological mechanisms that protect centenarians may help identify new strategies to delay disease onset, preserve functional independence and extend healthspan—the years of life lived in good health.

For clinicians, these findings reinforce an important principle of longevity medicine: the primary goal should be to delay—or ideally prevent—the development of chronic diseases, rather than simply improving survival after disease occurs.

The remarkable health resilience observed in centenarians suggests that cardiovascular disease, stroke, diabetes and many cancers are not inevitable consequences of aging. Instead, their onset may be substantially postponed through a combination of favourable genetics, lifelong healthy behaviours and effective management of cardiometabolic risk factors.

These observations strengthen the rationale for early preventive assessments, comprehensive cardiovascular and metabolic risk evaluation, and personalised lifestyle interventions aimed at preserving health long before clinical disease develops. Rather than extending the years lived with illness, longevity medicine seeks to maximise the number of years lived in good health, independence and functional capacity.